Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Biological Products × Clear all

NCT01413087 2019-11-01

LAPC-BC-819

Phase 2 Terminated

12 enrolled 19 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms